Analystreport

PDS Biotechnology Co. (NASDAQ: PDSB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

PDS Biotechnology Corporation  (PDSB) 
Last pds biotechnology corporation earnings: 11/7 06:00 am Check Earnings Report